Arthroscopic bone block with distal tibia allograft may aid posterior glenoid bone loss

While conservative management may provide adequate relief of symptoms for some patients, surgery is indicated for recurrent instability, with special attention paid toward patients with anatomy predisposing to failure of nonoperative treatment, including posterior Bankart lesions, excessive capsulol...

Full description

Saved in:
Bibliographic Details
Published inOrthopedics Today Vol. 44; no. 6; pp. 4 - 6
Main Authors Sarac, Nikolas, Bishop, Julie Y, Jones, Grant L
Format Journal Article Trade Publication Article
LanguageEnglish
Published Thorofare Slack, Inc 01.06.2024
SLACK INCORPORATED
Subjects
Bone surgery
Editorials
Editors
Orthopedics
Patients
Range of motion
Surgical techniques
Trademarks
Transplantation of organs, tissues, etc
Visualization
United States > US
Ohio
Online AccessGet full text
ISSN0279-5647

Cover

More Information
Summary:While conservative management may provide adequate relief of symptoms for some patients, surgery is indicated for recurrent instability, with special attention paid toward patients with anatomy predisposing to failure of nonoperative treatment, including posterior Bankart lesions, excessive capsulolabral laxity, excessive glenoid or humeral retroversion and glenoid bone loss. Attention was turned to the posterior labrum which, consistent with preoperative imaging, demonstrated significant posterior bone loss with associated labral tearing (Figure 2). Julie Y. Bishop, MD, Grant L. Jones, MD, and Nikolas Sarac, MD, are of the sports medicine and shoulder divisions at The Ohio State University Wexner Medical Center in Columbus, Ohio. Unsolicited physician-written and other expert-written original articles are encouraged but also are subject to the editorial process and additional review by the appropriate subspecialty Section Editor. Because Orthopedics Today® reports on emerging technologies, techniques and medical therapies, some reports may discuss drug and device applications that either are not approved by the appropriate regulatory body and/or the U.S. Food and Drug Administration or are not considered to be within the standard practice of medicine.
ISSN:0279-5647